
    
      1. To evaluate whether Rebamipide facilitate the healing of inflamed mucosa as an adjuvant
           regimen in erosive reflux esophagitis patients

        2. To evaluate the safety of rebamipide as an adjuvant regimen in erosive reflux
           esophagitis (ERE)
    
  